Indie Asset Partners »

Aziyo Biologics shares owned by Indie Asset Partners

Quarter-by-quarter ownership of Aziyo Biologics (ELUT) shares owned by Indie Asset Partners from 13F filings

Historical chart of Indie Asset Partners investment in Aziyo Biologics

Tip: Access up to 7 years of quarterly data

All positions including Aziyo Biologics held by Indie Asset Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aziyo Biologics by Indie Asset Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $65k 30k 2.16
2023-09-30 $39k 27k 1.43
2023-06-30 $63k 27k 2.36
2023-03-31 $40k 27k 1.51

More positions owned by Indie Asset Partners

Eli Lilly & Co. (LLY)
Royalty Pharma Shs Class A (RPRX)
Atlas Energy Solutions Com New (AESI)
Apple (AAPL)
Microsoft Corporation (MSFT)
Spdr Ser Tr S&p 600 Smcp Val (SLYV)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Vanguard World Fds Energy Etf (VDE)
Meta Platforms Cl A (META)
Spdr Ser Tr S&P 600 SMCP GRW (SLYG)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Amazon (AMZN)
Ishares Tr Us Hlthcare Etf (IYH)
Ishares Tr Us Trsprtion (IYT)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)

View all positions for Indie Asset Partners

Top funds holding Aziyo Biologics

AIGH Capital Management
Nantahala Capital Management
Alyeska Investment Group
Perkins Capital Management
Worth Venture Partners
Vanguard Group
Indie Asset Partners
Millennium Management
Verdence Capital Advisors
Virtu Financial
Us Bancorp
UBS Group
Royal Bank of Canada
Wells Fargo & Company
Jpmorgan Chase & Co

View all funds holding Aziyo Biologics